Skip to main content
NCBI home page
Clinical and Experimental Immunology logoLink to Clinical and Experimental Immunology
. 1992 Oct;90(1):36–42. doi: 10.1111/j.1365-2249.1992.tb05828.x

IL-2 regulation of soluble IL-2 receptor levels following thermal injury.

J A Teodorczyk-Injeyan 1, B G Sparkes 1, S Lalani 1, W J Peters 1, G B Mills 1
PMCID: PMC1554529  PMID: 1382903

Abstract

In the immunosuppressed burn patient serum levels of both IL-2 and a soluble form of IL-2 receptor alpha (sIL-2R alpha) are significantly elevated. Strikingly, the production of these markers by the in vitro activated patients' cells is decreased. This study examines the role of IL-2 in the decreased production of the sIL-2R alpha in vitro in patients with major burns (n = 18, 30 to greater than 70% total body surface area). Peripheral blood mononuclear cell (PBMC) cultures from patients with highly elevated serum sIL-2R alpha, and from healthy controls (n = 12) were activated with concanavalin A (Con A) at initiation. In patients' cultures mitogen-induced increments of sIL-2R alpha levels were significantly lower. There was a significant negative correlation (r = 0.64, P less than 0.001) between a high serum sIL-2R alpha level and a decreased lectin-induced sIL-2R alpha release in vitro. Low levels of sIL-2R alpha in patients' samples were not normalized by increasing the number of T lymphocytes. Also exogenous rIL-1 was without effect, whereas rIL-3 increased sIL-2R alpha release in some cultures. However, sIL-2R alpha levels were significantly increased in patients' cultures by (i) addition of exogenous IL-2; (ii) removal of adherent cells; (iii) addition of cyclooxygenase inhibitor, indomethacin; (iv) bypassing cell surface activation by the combination of the calcium ionophore A23187 and the phorbol ester 12-o-tetradecanoyl acetate. The cyclic AMP-elevating drug, forskolin, abrogated the ability of exogenous IL-2 to increase sIL-2R alpha production. Thus, in the burn patient, the reduced in vitro sIL-2R alpha release appears to relate to abnormalities in IL-2 production and action mediated through its functional surface receptor. Elevated levels of sIL-2R alpha in vivo may, therefore, reflect systemic activation of T lymphocytes in response to biologically active IL-2.

Full text

PDF
36

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Averill L. E., Stein R. L., Kammer G. M. Control of human T-lymphocyte interleukin-2 production by a cAMP-dependent pathway. Cell Immunol. 1988 Aug;115(1):88–99. doi: 10.1016/0008-8749(88)90164-5. [DOI] [PubMed] [Google Scholar]
  2. Barral-Netto M., Barral A., Santos S. B., Carvalho E. M., Badaro R., Rocha H., Reed S. G., Johnson W. D., Jr Soluble IL-2 receptor as an agent of serum-mediated suppression in human visceral leishmaniasis. J Immunol. 1991 Jul 1;147(1):281–284. [PubMed] [Google Scholar]
  3. Birchenall-Sparks M. C., Farrar W. L., Rennick D., Kilian P. L., Ruscetti F. W. Regulation of expression of the interleukin-2 receptor on hematopoietic cells by interleukin-3. Science. 1986 Jul 25;233(4762):455–458. doi: 10.1126/science.3088729. [DOI] [PubMed] [Google Scholar]
  4. Depper J. M., Leonard W. J., Drogula C., Krönke M., Waldmann T. A., Greene W. C. Interleukin 2 (IL-2) augments transcription of the IL-2 receptor gene. Proc Natl Acad Sci U S A. 1985 Jun;82(12):4230–4234. doi: 10.1073/pnas.82.12.4230. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Ertel W., Faist E., Nestle C., Hueltner L., Storck M., Schildberg F. W. Kinetics of interleukin-2 and interleukin-6 synthesis following major mechanical trauma. J Surg Res. 1990 Jun;48(6):622–628. doi: 10.1016/0022-4804(90)90242-t. [DOI] [PubMed] [Google Scholar]
  6. Faist E., Mewes A., Strasser T., Walz A., Alkan S., Baker C., Ertel W., Heberer G. Alteration of monocyte function following major injury. Arch Surg. 1988 Mar;123(3):287–292. doi: 10.1001/archsurg.1988.01400270021002. [DOI] [PubMed] [Google Scholar]
  7. Guo Y., Dickerson C., Chrest F. J., Adler W. H., Munster A. M., Winchurch R. A. Increased levels of circulating interleukin 6 in burn patients. Clin Immunol Immunopathol. 1990 Mar;54(3):361–371. doi: 10.1016/0090-1229(90)90050-z. [DOI] [PubMed] [Google Scholar]
  8. Jenkins M. K., Miller R. A. Memory and anergy: challenges to traditional models of T lymphocyte differentiation. FASEB J. 1992 Apr;6(7):2428–2433. doi: 10.1096/fasebj.6.7.1563595. [DOI] [PubMed] [Google Scholar]
  9. Johnson K. W., Davis B. H., Smith K. A. cAMP antagonizes interleukin 2-promoted T-cell cycle progression at a discrete point in early G1. Proc Natl Acad Sci U S A. 1988 Aug;85(16):6072–6076. doi: 10.1073/pnas.85.16.6072. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Johnson K. W., Smith K. A. cAMP regulation of IL-2 receptor expression. Selective modulation of the p75 subunit. J Immunol. 1990 Aug 15;145(4):1144–1151. [PubMed] [Google Scholar]
  11. Kaplan M. E., Clark C. An improved rosetting assay for detection of human T lymphocytes. J Immunol Methods. 1974 Jul;5(2):131–135. doi: 10.1016/0022-1759(74)90003-9. [DOI] [PubMed] [Google Scholar]
  12. Krause D. S., Deutsch C. Cyclic AMP directly inhibits IL-2 receptor expression in human T cells: expression of both p55 and p75 subunits is affected. J Immunol. 1991 Apr 1;146(7):2285–2296. [PubMed] [Google Scholar]
  13. Lang J. M., Coumaros G., Levy S., Falkenrodt A., Steckmeyer M., Partisani M., Aleksijevic A., Lehr L., Koehl C. Elevated serum levels of soluble interleukin 2 receptors in HIV infection: correlation studies with markers of cell activation. Immunol Lett. 1988 Oct;19(2):99–102. doi: 10.1016/0165-2478(88)90126-5. [DOI] [PubMed] [Google Scholar]
  14. Lawrence E. C., Brousseau K. P., Berger M. B., Kurman C. C., Marcon L., Nelson D. L. Elevated concentrations of soluble interleukin-2 receptors in serum samples and bronchoalveolar lavage fluids in active sarcoidosis. Am Rev Respir Dis. 1988 Apr;137(4):759–764. doi: 10.1164/ajrccm/137.4.759. [DOI] [PubMed] [Google Scholar]
  15. Miller-Graziano C. L., Fink M., Wu J. Y., Szabo G., Kodys K. Mechanisms of altered monocyte prostaglandin E2 production in severely injured patients. Arch Surg. 1988 Mar;123(3):293–299. doi: 10.1001/archsurg.1988.01400270027003. [DOI] [PubMed] [Google Scholar]
  16. Mills G. B., Cheung R. K., Grinstein S., Gelfand E. W. Increase in cytosolic free calcium concentration is an intracellular messenger for the production of interleukin 2 but not for expression of the interleukin 2 receptor. J Immunol. 1985 Mar;134(3):1640–1643. [PubMed] [Google Scholar]
  17. Robb R. J., Kutny R. M. Structure-function relationships for the IL 2-receptor system. IV. Analysis of the sequence and ligand-binding properties of soluble Tac protein. J Immunol. 1987 Aug 1;139(3):855–862. [PubMed] [Google Scholar]
  18. Rubin L. A., Kurman C. C., Fritz M. E., Biddison W. E., Boutin B., Yarchoan R., Nelson D. L. Soluble interleukin 2 receptors are released from activated human lymphoid cells in vitro. J Immunol. 1985 Nov;135(5):3172–3177. [PubMed] [Google Scholar]
  19. Symons J. A., Wood N. C., Di Giovine F. S., Duff G. W. Soluble IL-2 receptor in rheumatoid arthritis. Correlation with disease activity, IL-1 and IL-2 inhibition. J Immunol. 1988 Oct 15;141(8):2612–2618. [PubMed] [Google Scholar]
  20. Takayama T. K., Miller C., Szabo G. Elevated tumor necrosis factor alpha production concomitant to elevated prostaglandin E2 production by trauma patients' monocytes. Arch Surg. 1990 Jan;125(1):29–35. doi: 10.1001/archsurg.1990.01410130031004. [DOI] [PubMed] [Google Scholar]
  21. Teodorczyk-Injeyan J. A., Sparkes B. G., Falk R. E., Peters W. J., Mills G. B. Interleukin-2 secretion and transmembrane signalling in burned patients. J Trauma. 1988 Feb;28(2):152–157. doi: 10.1097/00005373-198802000-00004. [DOI] [PubMed] [Google Scholar]
  22. Teodorczyk-Injeyan J. A., Sparkes B. G., Mills G. B., Falk R. E., Peters W. J. Impaired expression of interleukin-2 receptor (IL2R) in the immunosuppressed burned patient: reversal by exogenous IL2. J Trauma. 1987 Feb;27(2):180–187. doi: 10.1097/00005373-198702000-00015. [DOI] [PubMed] [Google Scholar]
  23. Teodorczyk-Injeyan J. A., Sparkes B. G., Mills G. B., Falk R. E., Peters W. J. Increase of serum interleukin 2 receptor level in thermally injured patients. Clin Immunol Immunopathol. 1989 May;51(2):205–215. doi: 10.1016/0090-1229(89)90020-2. [DOI] [PubMed] [Google Scholar]
  24. Teodorczyk-Injeyan J. A., Sparkes B. G., Mills G. B., Peters W. J., Falk R. E. Impairment of T cell activation in burn patients: a possible mechanism of thermal injury-induced immunosuppression. Clin Exp Immunol. 1986 Sep;65(3):570–581. [PMC free article] [PubMed] [Google Scholar]
  25. Teodorczyk-Injeyan J. A., Sparkes B. G., Mills G. B., Peters W. J. Immunosuppression follows systemic T lymphocyte activation in the burn patient. Clin Exp Immunol. 1991 Sep;85(3):515–518. doi: 10.1111/j.1365-2249.1991.tb05759.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Teodorczyk-Injeyan J. A., Sparkes B. G., Mills G. B., Peters W. J. Soluble interleukin 2-receptor alpha secretion is related to altered interleukin 2 production in thermally injured patients. Burns. 1991 Aug;17(4):290–295. doi: 10.1016/0305-4179(91)90042-f. [DOI] [PubMed] [Google Scholar]
  27. Teodorczyk-Injeyan J. A., Sparkes B. G., Peters W. J. Serum interleukin-2 receptor as a possible mediator of immunosuppression after burn injury. J Burn Care Rehabil. 1989 Mar-Apr;10(2):112–118. doi: 10.1097/00004630-198903000-00003. [DOI] [PubMed] [Google Scholar]
  28. Weinberg A. D., Swain S. L. IL-2 receptor (Tac antigen) protein expression is down-regulated by the 5'-untranslated region of the mRNA. J Immunol. 1990 Jun 15;144(12):4712–4720. [PubMed] [Google Scholar]
  29. Wood J. J., Rodrick M. L., O'Mahony J. B., Palder S. B., Saporoschetz I., D'Eon P., Mannick J. A. Inadequate interleukin 2 production. A fundamental immunological deficiency in patients with major burns. Ann Surg. 1984 Sep;200(3):311–320. doi: 10.1097/00000658-198409000-00008. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Xiao G. X., Chopra R. K., Adler W. H., Munster A., Winchurch R. A. Altered expression of lymphocyte Il-2 receptors in burned patients. J Trauma. 1988 Dec;28(12):1669–1672. doi: 10.1097/00005373-198812000-00010. [DOI] [PubMed] [Google Scholar]

Articles from Clinical and Experimental Immunology are provided here courtesy of British Society for Immunology

RESOURCES